Toggle Main Menu Toggle Search

ePrints

Induction of GADD153 and Bak: Novel molecular targets of fenretinide-induced apoptosis of neuroblastoma

Lookup NU author(s): Professor Penny Lovat, Professor Andrew Pearson, Dr Chris Redfern

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Unlike 13-cis retinoic acid, the synthetic retinoid fenretinide induces apoptosis of neuroblastoma cells and in vitro acts synergistically with the chemotherapeutic drugs, cisplatin, etoposide and carboplatin. The stress-induced transcription factor GADD153 and the Bcl2-related protein Bak are upregulated in response to fenretinide. Although fenretinide is a partial retinoic acid receptor (RAR)-β/γ agonist, RARβ/γ antagonists do not block the induction of GADD153 or Bak by fenretinide. Conversely, the induction of GADD153 and Bak is blocked by antioxidants. Neither GADD153 or Bak were induced by chemotherapeutic agents but over expression of GADD153 results in increased sensitivity to fenretinide-induced apoptosis. Therefore, fenretinide induces apoptosis via RAR-dependent and -independent pathways in which the RAR-independent pathway is characterised by the reactive oxygen species-dependent induction of GADD153 and Bak. The targeting of GADD153 and Bak in neuroblastoma cells may be novel pathways for the development of drugs inducing apoptosis of neuroblastoma with improved tumour specificity. © 2003 Elsevier Science Ireland Ltd. All rights reserved.


Publication metadata

Author(s): Lovat, P.E., Oliverio, S., Corazzari, M., Ranalli, M., Pearson, A.D.J., Melino, G., Piacentini, M., Redfern, C.P.F.

Publication type: Article

Publication status: Published

Journal: Cancer Letters

Year: 2003

Volume: 197

Issue: 1-2

Pages: 157-163

Print publication date: 18/07/2003

ISSN (print): 0304-3835

ISSN (electronic): 1872-7980

URL: http://dx.doi.org/10.1016/S0304-3835(03)00098-3

DOI: 10.1016/S0304-3835(03)00098-3

PubMed id: 12880976


Altmetrics

Altmetrics provided by Altmetric


Actions

    Link to this publication


Share